ArticleFrontiers in psychiatry2026
Diverging trends in neurodevelopmental disorder diagnoses among children aged below 16 years in Kazakhstan (2014-2024): a national registry study.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Neurodevelopmental disorders are increasingly straining health systems. However, how these disorders are distributed across populations, or whether their occurrence is increasing, is still not fully understood. This study examined registry-based prevalence, temporal trends, geographic variation, and associated systemic factors in a Central Asian setting. Methods: We analysed national electronic health-registry data from Kazakhstan for children aged ≤15 years from 2014 to 2024 using a repeated cross-sectional design. The register is a prevalent "on-the-register" stock registry, and the unit of analysis is the registry record per child-year; the pooled total of 214,904 records therefore represents child-year observations rather than unique children. Annual registry-based prevalence was calculated against official population denominators. Temporal trends were modelled with negative-binomial regression and summarized as annual percent change (APC) and segmented regression; regional differences and associated factors were examined with Bayesian hierarchical and mixed-effects models. Results: Among the 214,904 registered records, intellectual disability made up the largest share at 60.8%, followed by autism spectrum disorder at 20.9%, other developmental disorders at 17.1%, and attention-deficit/hyperactivity disorder at 1.1%. Registry-based ASD prevalence rose steeply from 16.8 to 190.5 per 100,000 (APC +27.0%/year), accelerating after the 2021 policy expansion. In contrast, other developmental disorders (-7.8%/year) and ADHD (-10.2%/year) declined, while intellectual-disability prevalence remained essentially stable (APC -0.7%/year, not statistically significant). The decline in the share of intellectual disability therefore reflects a compositional shift driven by the increase in ASD. Marked geographic differences were observed, with higher registry-based ASD prevalence in metropolitan areas and northern and eastern regions, together with strong differences related to the diagnosing specialist. Discussion: These patterns indicate that registered neurodevelopmental diagnoses in Kazakhstan are shaped not only by epidemiology but heavily by changing diagnostic practices, specialist availability, reimbursement policy, and the organization of services. Registry-based estimates should therefore be interpreted as measures of ascertainment rather than of true population prevalence. This study offers a national perspective on registry-based trends in developing regions and emphasizes the importance of systemic factors when planning services and estimating the true burden of these disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.